John Lechleiter, Chairman, President and Chief Executive Officer, Eli Lilly and Company

Leadership Along the Path We Have Chosen
Tuesday, March 31, 2015

[soundcloud url=”https://api.soundcloud.com/tracks/200968043″ params=”color=ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false” width=”100%” height=”166″ iframe=”true” /]

John Lechleiter has served as president and chief executive officer of Eli Lilly and Company since, and became chairman of the board of directors in 2009. John joined Lilly in 1979 as a senior organic chemist in process research and     development and became head of that department.  He began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England, and later held roles in project management, regulatory affairs, product development, and pharma operations. In 2005, he was named president and CEO and joined the board of directors.

John earned a bachelor’s degree in chemistry from Xavier University and master’s and doctoral degrees in organic chemistry from Harvard University.  John has received honorary doctorates from Marian University (Indianapolis, Indiana), the University of Indianapolis, the National University of Ireland, Indiana University, and Franklin College. He is a member of the American Chemical Society and Business Roundtable.  He serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), as chairman of the U.S.-Japan Business Council and of United Way Worldwide, and on the boards of the Life Sciences Foundation, and the Central Indiana Corporate Partnership.  He also serves on the boards of Nike, Inc. and Ford Motor Company.